Table 3.
The top 10 ranked pathways and FDR-corrected p-values obtained by combining AML data using NBIA. The horizontal line represents the cutoff of 5%. The target pathway Acute myeloid leukemia is ranked on top with an FDR-adjusted p-value of 0.0066.
| NBIA | ||
|---|---|---|
| Pathway | p.fdr | |
| 1 | Acute myeloid leukemia | 0.0066 |
| 2 | Neurotrophin signaling pathway | 0.0178 |
| 3 | Non-small cell lung cancer | 0.0353 |
| 4 | Renal cell carcinoma | 0.0353 |
| 5 | Transcriptional misregulation in cancer | 0.0384 |
| 6 | ErbB signaling pathway | 0.0628 |
| 7 | Non-alcoholic fatty liver disease (NAFLD) | 0.1461 |
| 8 | Colorectal cancer | 0.1913 |
| 9 | Insulin resistance | 0.2792 |
| 10 | Endometrial cancer | 0.2792 |